Nura Bio is a biotechnology company that develops neuroprotective therapies for neurological disorders. Its research focuses on preserving neuronal integrity by targeting pathways involved in axonal degeneration and neuroimmune regulation. The company is advancing small-molecule programs, including inhibitors of the SARM1 protein, which plays a key